Match Document Document Title
7390654 Avoidance of undesirable replication intermediates in plasmid propagation  
Disclosed herein are improved plasmid shuttle vectors, vaccines based on them, and methods related to their construction and use. Particular arrangements of functional elements of such plasmids,...
7381804 G-CSF analog compositions and methods  
The present invention relates to granulocyte colony-stimulating factor (“G-CSF”) hybrid molecules which retain the internal core helices of G-CSF. Also provided are pharmaceutical compositions...
7361486 Polynucleotide, vector, host cell and method for producing human hepatoma-derived growth factor 5 polypeptide  
The invention provides a cDNA sequence of human hepatoma derived growth factor 5 (HDGF5). The present invention also relates to the polypeptides encoded by the nucleotide sequences, the uses of...
7358341 Beta-like glycoprotein hormone polypeptide and heterodimer  
Novel β10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods...
7354739 TML polynucleotides  
The present invention is directed to polynucleotides, peptides, variants, and uses thereof for a novel peptide fragment designated TML peptides. Binding of the peptide fragment has been shown in...
7351815 Canine pre-proGHRH and mature GHRH genes  
The present invention relates to a canine pre-proGHRH polypeptide, a canine mature GHRH peptide, an isolated polynucleotide which encodes the canine pre-proGHRH or the canine mature GHRH. The...
7345154 Cysteine variants of erythropoietin  
The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific, biologically active...
7338787 Nucleic acids encoding OBG3 globular head and uses thereof  
The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight...
7317095 Mutant glycoproteins  
The inventors have designed novel FSH mutants with increased glycosylation and longer half-lives for use in inducing folliculogenesis in human patients. The use of a FSH mutant preparation of the...
7314734 Muteins of placental growth factor type 1, preparation method and application thereof  
The present invention relates to chemically stable muteins of type 1 Placental Growth Factor (PLGF-1) bearing the substitution or elimination of a cysteine residue from the wild type protein amino...
7314626 Use of peptide vectors to improve the immune response to antigens  
The invention relates to conjugates of an antigen coupled to a linear derivative of a β-stranded antibiotic peptide, which are useful for immunogenic agents to enhance a CTL response. Two groups...
7294483 Process for producing recombinant polypeptides via a glycerol phosphate or sugar phosphate feed  
A process is described for producing a polypeptide heterologous to E. coli wherein E. coli cells comprising nucleic acid encoding the polypeptide are cultured in a culture medium while feeding...
7291483 FGF-CX polynucleotide sequences and methods of producing same  
The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant,...
7262166 Chemically modified novel erythropoietin stimulating protein compositions and methods  
The present invention broadly relates to the field of protein modification, and, more specifically, the attachment of water soluble polymers to novel erythropoietin stimulating protein (NESP).
7259293 Expression of eukaryotic peptides in plant plastids  
Constructs and methods are provided for expressing peptides derived from eukaryotic organisms in plant plastids. Constructs have a promoter functional in a plant plastid, a DNA sequence encoding a...
7247452 Truncated keratinocyte growth factor (KGF) having increased biological activity  
The present invention relates to a keratinocyte growth factor fragment, KGF des1-23 , or an analog thereof that is composed of a portion of an amino acid sequence of mature, full length...
7244591 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone  
Novel Saccharomyces Cerevisiae mutant strains are provided for producing human parathyroid hormone. The novel strains acre genetically disrupted in at least one of the genes encoding the yapsin...
7238790 PRO1313 polypeptides  
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid...
7238657 Cartilage/Bone inducing materials for preparation  
A cartilage and bone morphogenetic repairing composition which contains a bone morphogenetic protein and a polyoxyethylene-polyoxypropylene glycol is disclosed. It is preferable that the molecular...
7232667 Keratinocyte growth factor-2 polynucleotides  
This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such...
7229793 Constructs and cells for production of small peptides  
The present invention features a nucleic acid construct for expressing a product, e.g., a small peptide such as GLP-1. The construct includes a nucleic acid sequence encoding a signal peptide and a...
7226758 Nucleic acids encoding glial cell line-derived neurotrophic factor (GDNF)  
A novel neurotrophic factor referred to as glial cell line-derived neurotrophic factor (GDNF) has been identified and isolated from serum free growth conditioned medium of B49 glioblastoma cells....
7223564 Four-helical bundle protein zsig81  
This present invention is directed to polypeptide and polynucleotide molecules that encode a four-helical bundle cytokine. The cytokine has been designated zsig81, and has restricted expression in...
7223563 Fibroblast growth factor (FGF23) nucleic acids  
The invention relates to novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR)....
7193042 Methods for purifying authentic IGF from yeast hosts  
Methods for purifying authentic, properly folded IGF polypeptides from yeast transformants are disclosed. The methods include a refolding step and provide for high yields of authentic IGF from a...
7179621 Pigment epithelium-derived factor: sequence of the PEDF gene  
Nucleic acids encoding the neurotrophic protein known as pigment epithelium derived factor (PEDF), a truncated version of PEDF referred to as rPEDF, and equivalent proteins, vectors comprising such...
7166446 Method for expression of heterologous proteins in yeast  
Compositions and methods for expression of heterologous mammalian proteins and their secretion in the biologically active mature form using a yeast host cell as the expression system are provided....
7153943 Derivatives of growth hormone and related proteins, and methods of use thereof  
The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific, biologically active...
7148333 Cysteine variants of granulocyte-macrophage colony-stimulating factor  
The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific, biologically active...
7141392 Latent fusion protein  
The present invention provides a method for providing latency to a pharmaceutically active agent. The method has application in overcoming the toxic effect of systemic administration of potent...
7141389 Chromosome DNA coding for human hepatocyte growth factor  
A chromosome DNA which codes for human hepatocyte growth factor, a recombinant expression vector capable of expressing the DNA, a transformant transformed with the expression vector and a method of...
7129211 Adipocyte Insulin adpinsl with Insulin A and B chains and an effective method of treating type 2 diabetes in a subject using adipocyte insulin  
The present invention relates to an adipocyte Insulin adpInsl with Insulin A and B chains of SEQ ID Nos. 1 and 2, a effective method of treating type 2 diabetes in a subject using adipocyte...
7122654 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use  
VEGF-D, a new member of the PDGF family of growth factors, which among other things stimulates endothelial cell proliferation and angiogenesis and increases vascular permeability, as well as...
7122351 Dimerized PDGF-D and materials and methods for producing it  
Proteins consisting of two PDGF-D polypeptide chains, polynucleotides encoding the polypeptides, and materials and methods for making the proteins are disclosed. Each of the polypeptide chains...
7101981 Bovine growth hormone recombinantly produced in E. coli  
Recombinant materials have been obtained which permit the production of bovine growth hormone in E. coli.
7094411 Avirulent, immunogenic flavivirus chimeras  
Chimeric flaviviruses that are avirulent and immunogenic are provided. The chimeric viruses are constructed to contain amino acid mutations in the nonstructural proteins of a flavivirus. Chimeric...
7091401 Expression of epidermal growth factor in plant seeds  
The present invention provides a method of preparing epidermal growth factors in plants and transgenic plant seeds containing epidermal growth factors. The method provides an economical way to...
7090834 Vascular endothelial cell growth factor variants and uses thereof  
The present invention provides VEGF variants having one or more amino acid mutations in the KDR and/or FLT-1 receptor binding domains in the native VEGF sequence and selective binding affinity for...
7087739 Nucleic acid encoding recombinant salmon calcitonin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith  
Nucleic acid encoding recombinant salmon calcitonin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith. The nucleic acid encoding recombinant salmon...
7087408 Method for making insulin precursors and insulin precursor analogs  
Novel insulin precursors and insulin precursor analogs having a mini C-peptide comprising at least one aromatic amino acid residue have an increased folding stability. The novel insulin precursors...
7070788 Follicle stimulating hormone superagonists  
The invention is directed toward a human glycoprotein hormone having at least one, two, three, four, or five basic amino acids in the α-subunit at positions selected from the group consisting of...
7060795 Wound care compositions  
The invention provides polypeptides that can inhibit the activity of matrix metalloproteinases. Such polypeptides are useful for treating wounds, for example, chronic wounds.
7037684 Process for producing polypeptide having disulfide bond  
The invention relates to a DNA that enables co-expression of a protein disulfide isomerase and a polypeptide having disulfide bonds. The invention further relates to a process of producing...
6987172 Multifunctional single chain glycoprotein hormones comprising three or more β subunits  
Glycosylated or nonglycosylated molecules of the formula β 1 -(linker 1 ) n 1 -β 2 -(linker 2 ) n 2 -β 3 -(linker 3 ) n 3 -α; ...
6967092 Multi-functional chimeric hematopoietic receptor agonists  
Disclosed are novel multi-functional chimeric hematopoietic receptor agonist proteins, DNAs which encode the multi-functional chimeric hematopoietic receptor agonist proteins, methods of making the...
6967091 OBG3 globular head and uses thereof for decreasing body mass  
The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight...
6962796 Production of human parathyroid hormone from microorganisms  
The invention provides recombinant plasmids containing in DNA sequences coding for human preproparathyroid hormone. The invention further provides microorganisms, for example E. coli , transformed...
6953844 Isolation of neurotrophins from a mixture containing neurotrophin variants using hydrophobic interaction chromatography  
Methods are provided for large scale purification of neurotrophins, including mature NGF, suitable for clinical use. The methods provide means to separate neurotrophins from various less desirable...
6949365 Polynucleotides encoding lamprey GnRH-III  
Novel isolated cDNA encoding the precursor of the novel gonadotropin-releasing hormones in four species of the fish lamprey is disclosed. The use of such cDNA's in studying the phylogenetic...
6946444 Lipoprotein-regulating medicaments  
Methods and pharmaceutical compositions useful for modulating lipoprotein levels in vivo. The invention stems from the discovery that activity of the Lipolysis Stimulated Receptor (LSR) can be...